These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 7681406

  • 1. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors.
    Gully D, Fréhel D, Marcy C, Spinazzé A, Lespy L, Neliat G, Maffrand JP, Le Fur G.
    Eur J Pharmacol; 1993 Feb 23; 232(1):13-9. PubMed ID: 7681406
    [Abstract] [Full Text] [Related]

  • 2. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
    Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1995 Jan 23; 114(2):339-48. PubMed ID: 7881733
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
    Ballaz S, Barber A, Fortuño A, Del Río J, Martin-Martínez M, Gómez-Monterrey I, Herranz R, González-Muñiz R, García-López MT.
    Br J Pharmacol; 1997 Jun 23; 121(4):759-67. PubMed ID: 9208145
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
    Taniguchi H, Yazaki N, Endo T, Nagasaki M.
    Eur J Pharmacol; 1996 May 23; 304(1-3):147-54. PubMed ID: 8813597
    [Abstract] [Full Text] [Related]

  • 5. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
    Chang RS, Lotti VJ.
    Proc Natl Acad Sci U S A; 1986 Jul 23; 83(13):4923-6. PubMed ID: 3014520
    [Abstract] [Full Text] [Related]

  • 6. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
    Lotti VJ, Pendleton RG, Gould RJ, Hanson HM, Chang RS, Clineschmidt BV.
    J Pharmacol Exp Ther; 1987 Apr 23; 241(1):103-9. PubMed ID: 2437282
    [Abstract] [Full Text] [Related]

  • 7. Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist.
    Poncelet M, Arnone M, Heaulme M, Gonalons N, Gueudet C, Santucci V, Thurneyssen O, Keane P, Gully D, Le Fur G.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul 23; 348(1):102-7. PubMed ID: 8397341
    [Abstract] [Full Text] [Related]

  • 8. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
    Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1992 May 23; 106(1):61-6. PubMed ID: 1504732
    [Abstract] [Full Text] [Related]

  • 9. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 23; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.
    Akiyama T, Tachibana I, Hirohata Y, Shirohara H, Yamamoto M, Otsuki M.
    Br J Pharmacol; 1996 Apr 23; 117(7):1558-64. PubMed ID: 8730754
    [Abstract] [Full Text] [Related]

  • 11. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.
    Lotti VJ, Chang RS.
    Eur J Pharmacol; 1989 Mar 21; 162(2):273-80. PubMed ID: 2721567
    [Abstract] [Full Text] [Related]

  • 12. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC, Zhang L, Chiang HC, Wank SA, Maton PN, Gardner JD, Jensen RT.
    Am J Physiol; 1989 Jul 21; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist: comparison to loxiglumide.
    Ito H, Sogabe H, Nakarai T, Sato Y, Tomoi M, Kadowaki M, Matsuo M, Tokoro K, Yoshida K.
    J Pharmacol Exp Ther; 1994 Feb 21; 268(2):571-5. PubMed ID: 7509389
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo.
    Taniguchi H, Yazaki N, Yomota E, Shikano T, Endo T, Nagasaki M.
    Eur J Pharmacol; 1996 Sep 26; 312(2):227-33. PubMed ID: 8894600
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological profile of KSG-504, a new cholecystokinin-A-receptor antagonist.
    Yamazaki Y, Akahane M, Kobayashi M, Kitazawa M, Kurashina Y, Iizuka K.
    Jpn J Pharmacol; 1993 Oct 26; 63(2):219-25. PubMed ID: 7506805
    [Abstract] [Full Text] [Related]

  • 16. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ, Tang KW, Woodruff GN, McKnight AT.
    Br J Pharmacol; 1993 Aug 26; 109(4):913-7. PubMed ID: 8401944
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.
    Bertrand P, Böhme GA, Durieux C, Guyon C, Capet M, Jeantaud B, Boudeau P, Ducos B, Pendley CE, Martin GE.
    Eur J Pharmacol; 1994 Sep 12; 262(3):233-45. PubMed ID: 7813588
    [Abstract] [Full Text] [Related]

  • 18. Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists.
    Singh L, Field MJ, Hill DR, Horwell DC, McKnight AT, Roberts E, Tang KW, Woodruff GN.
    Eur J Pharmacol; 1995 Nov 14; 286(2):185-91. PubMed ID: 8605955
    [Abstract] [Full Text] [Related]

  • 19. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
    O'Neill MF, Dourish CT, Iversen SD.
    Eur J Pharmacol; 1991 Feb 07; 193(2):203-8. PubMed ID: 2050197
    [Abstract] [Full Text] [Related]

  • 20. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists.
    Varga G, Scarpignato C.
    Eur J Pharmacol; 1996 Jun 13; 306(1-3):153-9. PubMed ID: 8813627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.